TMCnet News
Research and Markets: Enterococcus Faecium Infections - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/hvlwkm/enterococcus) has announced the addition of the "Enterococcus Faecium Infections - Pipeline Review, H2 2013" report to their offering. 'Enterococcus Faecium Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Enterococcus Faecium Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Enterococcus Faecium Infections.
- A snapshot of the global therapeutic scenario for Enterococcus Faecium Infections. - A review of the Enterococcus Faecium Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Enterococcus Faecium Infections pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Dainippon Sumitomo Pharma Co., Ltd. Aquapharm Biodiscovery Limited Cellceutix Corporation Omnia Molecular Ltd. Biota Pharmaceuticals, Inc. Abgentis Limited Melinta Therapeutics Inc. For more information visit http://www.researchandmarkets.com/research/hvlwkm/enterococcus About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
